PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

Authors :: Mary Cifaldi
Sumati Rao
Patrizia Giannantoni
L. Gitto
Andrea Marcellusi
Francesco Saverio Mennini
Nick Bansback
Simone Russo
Source :: Value in Health. (7):A444-A445
Publisher :: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Subjects :: Moderate to severe
medicine.medical_specialty
business.industry
Health Policy
Public Health, Environmental and Occupational Health
medicine.disease
Dermatology
Psoriatic arthritis
Economic evaluation
Physical therapy
Adalimumab
Medicine
business
medicine.drug

Full Text Access

Tools